Actively Recruiting
Collection of Blood and Other Samples from Adults With Cholestatic Liver Diseases and Healthy Volunteers Including Primary Biliary CirrhosisCholangitis and Primary Sclerosing Cholangitis
Led by Mayo Clinic · Updated on 2026-02-17
9150
Participants Needed
1
Research Sites
N/A
Total Duration
AI-Summary
What this Trial Is About
Researchers are creating a biobank of specimens and clinical data to help understand cholestatic liver diseases, specifically primary biliary cirrhosischolangitis PBC and primary sclerosing cholangitis PSC. This observational study collects information to support current and future research aimed at learning how these diseases begin and progress. Participants include those diagnosed with PSC, PBC, other chronic liver diseases, and individuals without liver disease. Samples of blood, saliva, stool, and urine are collected during visits, through mail-home kits, or remote phlebotomy. Bile samples and bile duct cells are collected only during necessary clinical procedures called ERCPs at Mayo Clinic. During the study, participants provide various biological samples and clinical data. Researchers will monitor the number of participants, types of samples collected, and clinical outcomes over 20 years. This long-term observation helps develop new tests for early detection and better understanding of disease progression.
CONDITIONS
Brief Title
Biobank for Cholestatic Liver Diseases.
Research Team
E
Erik Schlicht, CCRP, B.A.
J
Jackie Bianchi
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here